Trial intelligence / Profile preview

Squat-to-Stand vs Amyl Nitrite in HCM

NCT04905173Withdrawn

Sponsor
Mayo Clinic
Start
Nov 2021
Primary completion
May 2022
01

Overview

Open-label, single-arm trial, sponsored by Mayo Clinic. Primary endpoint: Severe provokable obstruction. Planned start Nov 2021; status: withdrawn.

Beyond the preview

Go deeper on NCT04905173.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04905173.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call